Adapalene
Sponsors
Galderma R&D, Wake Forest University, Allergan, Teva Pharmaceuticals USA, Galderma Brasil Ltda.
Conditions
Acne ScarsAcne VulgarisPhotoagingPhotodamage
Phase 1
Phase 2
Phase 3
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris
CompletedNCT00421993
Start: 2006-10-31End: 2007-12-31Updated: 2021-02-18
A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging
CompletedNCT01406080
Start: 2013-01-31End: 2015-11-30Updated: 2017-04-06
Phase 4
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1%
CompletedNCT00660985
Start: 2008-05-31End: 2008-11-30Updated: 2021-02-18
Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris
CompletedNCT00696449
Start: 2006-06-30End: 2009-10-31Updated: 2018-09-10
Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris
TerminatedNCT00829049
Start: 2007-10-31End: 2008-10-31Updated: 2012-09-12
Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia
CompletedNCT03626298
Start: 2016-08-01End: 2018-04-30Updated: 2018-08-13
Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris
NCT03866447
Start: 2019-10-01End: 2021-03-01Target: 80Updated: 2019-03-12